mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.09 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.085 |
0.09 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
BIBW2992 |
FIMM |
pan-cancer |
AAC |
0.26 |
0.1 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.1 |